New Zealand BIO30™  propolis is certified to contain at least 30 mg/g of bioflavonoids, the active flavonoid compounds responsible for the biological activity in propolis, and caffeic acids.

The high level of bioflavonoids in BIO30™  propolis is thought to be due to the plant sources available to bees in New Zealand’s remote and pristine environment.

BIO30™  propolis contains Caffeic Acid Phenethyl Ester (CAPE), a compound which cancer researchers have shown suppresses neurofibromatosis tumours.

New Zealand propolis is extremely high in the important dihydroflavonoids pinobanksin and pinocembrin, making up 70% of the flavonoid content, compared to levels of less than 10% in propolis from Brazil, Uruguay and China.